24 May 2013
Keywords: Helsinn, CheilJedang, Netupitant, Palonosetron, South Korea, CINV
Article | 25 September 2012
Privately-held Swiss company Helsinn Group says it has signed a license agreement with CJ CheilJedang of South Korea for Helsinn's ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 September 2012
23 May 2013
© 2013 thepharmaletter.com